FMT effective for CDI in patients with cirrhosis

Fecal microbiota transplantation was safe and effective for the treatment of Clostridioides difficile infection in patients with cirrhosis, according to study results.
Monika Fischer, MD, of the division of gastroenterology at Indiana University School of Medicine, and colleagues wrote that patients with cirrhosis are at higher risk for CDI due to dysbiosis, functional immunosuppression and frequent use of antibiotic therapies. However, the FMT working group has recommended against FMT for this population due to the potential for adverse events.
“Hospitalized patients with cirrhosis have

Source link

Related posts

Do Processed Foods Cause Gastrointestinal Disorders?


Health care professionals prefer public priming to counteract misinformation on social media


Confirming Complexity: Assessing Environmental and Genetic Risk Factors for Inflammatory Bowel Disease


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World